Title : 311C90 (Zolmitriptan), a novel centrally and peripheral acting oral 5-hydroxytryptamine-1D agonist: a comparison of its absorption during a migraine attack and in a migraine-free period.

Pub. Date : 1996 Jun

PMID : 8792040






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The oral absorption of a 10-mg oral dose of the novel 5-hydroxytryptamine (5HT1D) agonist, 311C90, was compared during a moderate or severe migraine headache and in a migraine-free period in an open, two-period study. Serotonin 5-hydroxytryptamine receptor 1D Homo sapiens